^
BIOMARKER:

AR-V7 negative

AR-V7 negative
Prostate Cancer
enzalutamide
Sensitive: C3 – Early Trials
AR-V7 negative
Prostate Cancer
AST-2970
Sensitive: C3 – Early Trials